FORCE FOREVER supplement tablets recalled for undisclosed drugs
GNMart LLC is recalling FORCE FOREVER 400mg tablets nationwide after the FDA found the product contains undisclosed Diclofenac and Dexamethasone. The Class I recall affects all lots of this dietary supplement product.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This product received an FDA Class I drug recall classification due to contamination with undisclosed pharmaceutical drugs (Diclofenac and Dexamethasone) in a product marketed as a dietary supplement. No reported illnesses or deaths are documented in the available information.
Plain-English summary
GNMart LLC is recalling FORCE FOREVER 400mg Tablets across the United States. The product is sold in 60-count bottles and marketed as a dietary supplement (SUPLEMENTO ALIMENTICIO).
The FDA determined that the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). FDA analysis found the product to be tainted with Diclofenac and Dexamethasone.
The recall affects 374 bottles distributed nationwide. All lots are subject to the recall, with an expiration date of March 27, 2030.
Consumers who have purchased this product should stop using it immediately and consult a healthcare provider if they have taken the product and experience any adverse effects.
The recalled product
- Product
- FORCE FOREVER 400mg Tablets, Huesos y articulaciones sin dolor, SUPLEMENTO ALIMENTICIO, 60-count bottles
- Manufacturer
- GNMart LLC
- Category
- Drug — Dietary Supplement
- Hazard
- unapproved-drugs
- diclofenac
- dexamethasone
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- All lots
- Exp. Date: 03/27/2030
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27